医学
内科学
胃切除术
辅助化疗
癌症
倾向得分匹配
化疗
外科
围手术期
胃肠病学
佐剂
阶段(地层学)
生物
古生物学
乳腺癌
作者
Hemant Kumar Singh,Vikram Anil Chaudhari,Swati Batra,Vikas S. Ostwal,Anant Ramaswamy,Smruti Mokal,Shailesh Vinayak Shrikhande,Manish Suresh BHANDARE
标识
DOI:10.1016/j.amjsurg.2021.10.036
摘要
Abstract Aim This study aimed to assess the impact of treatment sequencing on long-term survival, in distal gastric cancers (GCs) (stage IB/II/III). Methods This retrospective study included patients with distal GC undergoing D2 resection. Outcomes were compared between group 1 (surgery with adjuvant chemotherapy) and group 2 (perioperative chemotherapy with surgery). 1:1 matching for baseline characteristics (age, cT, and cN stage) was performed for outcome comparison. Results At a median follow-up of 47.5 months in the included 342 patients, the 5-year overall survival (OS) was 61.1% and disease-free survival (DFS) was 50.5%. OS was comparable in the unmatched (group 1, n = 118; group 2, n = 224) (HR 0.905, 95%CI 0.64–1.33, P = 0.615) and matched groups (group 1, n = 97; group 2, n = 97) (HR 0.77, 95% CI 0.48–1.26, P = 0.3). Conclusion D2 resection followed by adjuvant chemotherapy provides similar long-term outcomes as compared to perioperative chemotherapy approach for stage IB/II/III distal GCs.
科研通智能强力驱动
Strongly Powered by AbleSci AI